IL158289A0 - Mercaptoacetylamide derivatives, a process for their preparation and their use - Google Patents

Mercaptoacetylamide derivatives, a process for their preparation and their use

Info

Publication number
IL158289A0
IL158289A0 IL15828902A IL15828902A IL158289A0 IL 158289 A0 IL158289 A0 IL 158289A0 IL 15828902 A IL15828902 A IL 15828902A IL 15828902 A IL15828902 A IL 15828902A IL 158289 A0 IL158289 A0 IL 158289A0
Authority
IL
Israel
Prior art keywords
compounds
preparation
disclosed
mercaptoacetylamide derivatives
mercaptoacetylamide
Prior art date
Application number
IL15828902A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL158289A0 publication Critical patent/IL158289A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
IL15828902A 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use IL158289A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28330501P 2001-04-12 2001-04-12
GBGB0119305.1A GB0119305D0 (en) 2001-04-12 2001-08-08 Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (fr) 2001-04-12 2002-04-03 Derives de mercaptoacetylamide, procede de preparation et utilisation de ces composes

Publications (1)

Publication Number Publication Date
IL158289A0 true IL158289A0 (en) 2004-05-12

Family

ID=26246410

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15828902A IL158289A0 (en) 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use

Country Status (27)

Country Link
EP (1) EP1381605B1 (fr)
JP (1) JP4392167B2 (fr)
CN (1) CN1245404C (fr)
AT (1) ATE286898T1 (fr)
AU (1) AU2002304804B2 (fr)
BG (1) BG66387B1 (fr)
BR (1) BR0208889A (fr)
CA (1) CA2443488C (fr)
CZ (1) CZ299708B6 (fr)
DE (1) DE60202602T2 (fr)
EE (1) EE05272B1 (fr)
ES (1) ES2232752T3 (fr)
HK (1) HK1061690A1 (fr)
HR (1) HRP20030823B1 (fr)
HU (1) HU229612B1 (fr)
IL (1) IL158289A0 (fr)
MA (1) MA26098A1 (fr)
MX (1) MXPA03008613A (fr)
NO (1) NO325655B1 (fr)
NZ (1) NZ528825A (fr)
OA (1) OA12502A (fr)
PL (1) PL209338B1 (fr)
PT (1) PT1381605E (fr)
RU (1) RU2286346C2 (fr)
SI (1) SI1381605T1 (fr)
SK (1) SK287616B6 (fr)
WO (1) WO2002083671A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (fr) * 1990-10-18 2002-04-02 Timothy P. Burkholder Derives de mercaptoacetylamide utiles comme inhibiteurs de l'encephalinase et de l'ace
ATE155143T1 (de) * 1991-09-27 1997-07-15 Merrell Pharma Inc 2-substituierte indan-2-mercaptoacetylamid- verbindungen mit enkephalinase und ace- hemmwirkung
CA2140553A1 (fr) * 1993-06-11 1994-12-22 Hitoshi Oinuma Derive d'un acide amine

Also Published As

Publication number Publication date
CN1501926A (zh) 2004-06-02
CZ299708B6 (cs) 2008-10-29
SI1381605T1 (en) 2005-06-30
BG66387B1 (bg) 2013-11-29
HUP0303482A2 (hu) 2004-01-28
DE60202602T2 (de) 2006-03-23
BG108203A (bg) 2004-12-30
BR0208889A (pt) 2004-06-29
CN1245404C (zh) 2006-03-15
HRP20030823B1 (en) 2011-10-31
WO2002083671A1 (fr) 2002-10-24
EE200300500A (et) 2003-12-15
NZ528825A (en) 2005-04-29
EE05272B1 (et) 2010-02-15
JP2004525966A (ja) 2004-08-26
CA2443488A1 (fr) 2002-10-24
PL209338B1 (pl) 2011-08-31
MXPA03008613A (es) 2003-12-08
PL363034A1 (en) 2004-11-15
SK12552003A3 (sk) 2004-03-02
HU229612B1 (en) 2014-03-28
OA12502A (fr) 2006-05-29
ATE286898T1 (de) 2005-01-15
DE60202602D1 (de) 2005-02-17
CZ20032722A3 (cs) 2004-01-14
PT1381605E (pt) 2005-03-31
NO20034412L (no) 2003-10-02
CA2443488C (fr) 2011-05-31
RU2003132875A (ru) 2005-03-20
EP1381605A1 (fr) 2004-01-21
NO325655B1 (no) 2008-06-30
MA26098A1 (fr) 2004-04-01
AU2002304804B2 (en) 2007-05-10
HRP20030823A2 (en) 2005-08-31
EP1381605B1 (fr) 2005-01-12
ES2232752T3 (es) 2005-06-01
JP4392167B2 (ja) 2009-12-24
HK1061690A1 (en) 2004-09-30
SK287616B6 (sk) 2011-04-05
HUP0303482A3 (en) 2012-12-28
RU2286346C2 (ru) 2006-10-27
NO20034412D0 (no) 2003-10-02

Similar Documents

Publication Publication Date Title
TNSN03083A1 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
WO2003082857A3 (fr) Polymorphes de lansoprazole et procedes de preparation de ces derniers
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
WO2002065834A3 (fr) Nouvelles formulations de carvedilol
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
AP1766A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
YU61103A (sh) Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
WO2002010152A3 (fr) Nouveaux derives d'indol et leur utilisation comme medicaments
WO2004032908A3 (fr) Methode d'inhibition de l'angiogenese
SG165159A1 (en) Process for preparing 6-alkylidene penem derivatives
WO2005051401A3 (fr) Prevention et traitement de maladies cardiaques hypertensives a l'aide des oestrogenes selectifs 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol et 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol
IL158289A0 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
WO2003080631A8 (fr) Inhibiteurs de plasma carboxypeptidase b
WO2003035651A3 (fr) Derives de l'artemisinine, et leurs utilisations dans le traitement du paludisme
PL1651596T3 (pl) Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje
WO2003028645A3 (fr) Nouvelles compositions de carvedilol
WO2002085877A3 (fr) Procedes et intermediaires de preparation de benzyl epoxydes
AU2002326391A1 (en) Carvedilol polymorph
MXPA05003881A (es) Preparacion de compuestos triazospiro.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04002879A (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol.
WO2001068071A3 (fr) Utilisation de composes naturels possedant une activite angiogenique
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.